Stocks and Investing Stocks and Investing
Fri, March 31, 2023
Thu, March 30, 2023

Robert Burns Reiterated (BNTX) at Strong Buy and Held Target at $210 on, Mar 30th, 2023


Published on 2024-10-28 02:30:32 - WOPRAI, Robert Burns
  Print publication without navigation


Robert Burns of HC Wainwright & Co., Reiterated "BioNTech SE" (BNTX) at Strong Buy and Held Target at $210 on, Mar 30th, 2023.

Robert has made no other calls on BNTX in the last 4 months.



There are 7 other peers that have a rating on BNTX. Out of the 7 peers that are also analyzing BNTX, 5 agree with Robert's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Chris Shibutani of "Goldman Sachs" Maintained at Hold with Decreased Target to $140 on, Tuesday, March 28th, 2023
  • Matthew Korn of "Morgan Stanley" Maintained at Hold with Decreased Target to $150 on, Tuesday, March 28th, 2023
  • Yaron Werber of "TD Cowen" Maintained at Hold with Decreased Target to $130 on, Tuesday, March 28th, 2023
  • Jessica Fye of "JP Morgan" Maintained at Hold with Decreased Target to $142 on, Wednesday, February 8th, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $216 on, Tuesday, January 24th, 2023


These are the ratings of the 2 analyists that currently disagree with Robert


  • Bill Selesky of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $203 on, Tuesday, March 28th, 2023
  • Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Decreased Target to $194 on, Tuesday, March 28th, 2023
Contributing Sources